Arkolith/Insider Trading/SANA/Form 4

Wyrick Susan D.

See RemarksSana Biotechnology, Inc. (SANA) · full profile →Form 4 · filed Dec 16, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 15, 2025Tax withholding(F)873$5.22$5K181K
Dec 13, 2025Option exercise(M)3K—$0182K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 13, 2025Option exercise(M)3K——0

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001568605-25-000007) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML